Type 2 Diabetes: Simplifying Management with GLP-1RAs – Mainpro+

Upon completion of this program, participants will be able to:

1. Differentiate between the GLP-1RAs approved in Canada
2. Compare GLP-1RAs to oral antihyperglycemic agents or basal insulin on the basis of safety, efficacy, and cardiovascular outcomes
3. Integrate GLP-1RA therapy into effective type 2 diabetes management